SEP 19, 2019 12:40 PM PDT

Transplanted Brain Stem Cells Survive Without Anti-Rejection Drugs

WRITTEN BY: Nouran Amin

Researchers at Johns Hopkins Medicine have successfully transplanted brain cells without the need of immune-suppressing drugs. Findings of the study were published in the journal Brain which describes the newest approach in selectively circumventing immune responses against transplanted cells. The study serves as the basis for future therapeutic studies that may award renewed hope.

For example, every year approximately 1 of 100,000 children born in the U.S. will be born to a rare genetic disease such as Pelizaeus-Merzbacher disease that is characterized by infants missing developmental marks like sitting and walking, having involuntary muscle spasms, and the possibility of experiencing partial paralysis of the arms and legs, all caused by a genetic mutation in the genes that form myelin.

"Because these conditions are initiated by a mutation causing dysfunction in one type of cell, they present a good target for cell therapies, which involve transplanting healthy cells or cells engineered to not have a condition to take over for the diseased, damaged or missing cells," says Piotr Walczak, M.D., Ph.D., associate professor of radiology and radiological science at the Johns Hopkins University School of Medicine.

Learn more about transplantation rejection:

Researchers have pursued ways to alter T cells--the system's elite infection-fighting force that attacks foreign invaders. "These signals are in place to help ensure these immune system cells do not go rogue, attacking the body's own healthy tissues," says Gerald Brandacher, M.D., professor of plastic and reconstructive surgery and scientific director of the Vascularized Composite Allotransplantation Research Laboratory at the Johns Hopkins University School of Medicine and co-author of this study.

Source: Science Daily

About the Author
  • Nouran enjoys writing on various topics including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
OCT 17, 2019
Drug Discovery & Development
OCT 17, 2019
Novel Drug Target for Dilating Microvessels
Medical scientists at Augusta University have discovered a natural occurring chemical that dilates blood vessels dilate as well as signaling larger blood v...
OCT 17, 2019
Drug Discovery & Development
OCT 17, 2019
Promising Drug Encourages Survival in Pancreatic Cancer
Building on almost 20 years of research, a phase 1 clinical trial drug for pancreatic cancer, named ‘AZD1775’, shows promising initial results ...
OCT 17, 2019
Clinical & Molecular DX
OCT 17, 2019
Muscular Dystrophy Drug by Sarepta Therapeutics: Approval or Rejection by Drug Regulating Authorities?
Duchenne Muscular Dystrophy (DMD is a rare, genetic disorder that hampers muscle movement and is the most common pediatric muscular dystrophy. I...
OCT 17, 2019
Drug Discovery & Development
OCT 17, 2019
New Potential Early Stage Treatment for Parkinson's
Parkinson’s Disease is the second most common neurodegenerative condition, affecting 35 million people globally. Currently without a cure, researcher...
OCT 17, 2019
Genetics & Genomics
OCT 17, 2019
Non-Invasive Gene Therapy Holds Promise for Treating Blindness
Researchers at John Hopkins Medicine have found a way to deliver sight-saving gene therapy to the retina. Having already shown success in treating rates, p...
OCT 17, 2019
Drug Discovery & Development
OCT 17, 2019
Drug Increases Survival Rates for Heart Failure Patients
Scientists have demonstrated in preclinical studies that a drug called ‘Aliskiren’ works by inhibiting the activity of an enzyme involved in bl...
Loading Comments...